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Abstract
Background: Associations between measures of subjective health and mortality risk have previously been shown.
We assessed the impact and comparative predictive performance of a multi-biomarker panel on this association.
Methods: Data from 4,261 individuals aged 20-79 years recruited for the population-based Study of Health in
Pomerania was used. During an average 9.7 year follow-up, 456 deaths (10.7%) occurred. Subjective health was
assessed by SF-12 derived physical (PCS-12) and mental component summaries (MCS-12), and a single-item self-
rated health (SRH) question. We implemented Cox proportional-hazards regression models to investigate the
association of subjective health with mortality and to assess the impact of a combination of 10 biomarkers on this
association. Variable selection procedures were used to identify a parsimonious set of subjective health measures
and biomarkers, whose predictive ability was compared using receiver operating characteristic (ROC) curves, C-
statistics, and reclassification methods.
Results: In age- and gender-adjusted Cox models, poor SRH (hazard ratio (HR), 2.07; 95% CI, 1.34-3.20) and low
PCS-12 scores (lowest vs. highest quartile: HR, 1.75; 95% CI, 1.31-2.33) were significantly associated with increased
risk of all-cause mortality; an association independent of various covariates and biomarkers. Furthermore, selected
subjective health measures yielded a significantly higher C-statistic (0.883) compared to the selected biomarker
panel (0.872), whereas a combined assessment showed the highest C-statistic (0.887) with a highly significant
integrated discrimination improvement of 1.5% (p < 0.01).
Conclusion: Adding biomarker information did not affect the association of subjective health measures with
mortality, but significantly improved risk stratification. Thus, a combined assessment of self-reported subjective
health and measured biomarkers may be useful to identify high-risk individuals for intensified monitoring.
Keywords: Health-related quality of life, multiple biomarker panel, all-cause mortality, SF-12, population-based
cohort
Background
Subjective health measures are widely used within clini-
cal and epidemiological research, as well as health policy
settings, being easily assessed by a single-item self-rated
health (SRH) question or more thoroughly using health
related quality of life (HRQoL) instruments. The Short
Form Health Survey (SF-36) is a well documented and
validated HRQoL instrument [1-3], with the SF-12
developed as a shorter alternative. With the advantage
of two summary scores of physical (PCS-12) and mental
component summaries (MCS-12), the SF-12 has been
extensively applied in epidemiological studies [4].
In particular, the relationship between SRH and mor-
tality has been repeatedly reported [5-8], suggesting a
single measure of SRH as strong predictor of poor over-
all health status and increased mortality risk [9]. How-
ever, previous studies are limited by the fact that the
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have been assessed in elderly [10-12] or disease-specific
patient populations including conditions such as cancer
[13,14], diabetes mellitus [15], coronary artery disease
[16,17], respiratory disease [18,19], chronic kidney dis-
ease [20], or infection by HIV [21]. Beside these limita-
tions, the impact and comparative predictive
performance of different biomarkers on the association
between subjective health measures and mortality risk is
l a r g e l yu n k n o w n .T h i si se v e nm o r ei n t r i g u i n g ,a st h e
multi-biomarker approach has recently gained wide-
spread attention as powerful predictors of clinical
[22,23] and subclinical outcomes [24].
The present study aims to investigate the impact and
comparative predictive performance of a multi-biomar-
ker panel on the association of subjective health with
mortality, analyzing data from the 10-year follow-up of




The SHIP is a population-based cohort study in West
Pomerania, conducted in the north-eastern area of Ger-
many comprising the cities of Greifswald, Stralsund,
Anklam and 29 surrounding communities with a total
of 212,157 residents [25,26]. A representative sample of
7,008 adults aged 20 to 79 years was invited to partici-
pate. A two-stage cluster sampling method was adopted
for this purpose from the WHO MONICA in Germany
(Augsburg) and yielded twelve five-year age strata for
both genders, each including 292 individuals in a total
of 34 towns or villages. Only individuals with German
citizenship and main residency in the study area were
included. The net sample (without migrated or deceased
persons) comprised 6,267 eligible subjects, of which
4,308 finally participated (response proportion 68.8%).
Data collection was performed in two examination cen-
ters (Greifswald and Stralsund) between October 1997
and May 2001 after written consent was obtained from
each participant. The study conformed to the ethical
guidelines of the Declaration of Helsinki as reflected in
an a priori approval by the local Ethics Committee of
the University of Greifswald. Subjects with missing data
for the modelled variables (N = 49) were excluded,
yielding a study population of 4,259 individuals.
Measures
A computer-assisted personal interview assessed socio-
demographic information including age, gender, educa-
tional level (< 10, = 10, or > 10 years of education), civil
status (cohabitation), and occupational status (having no
paid job, worker, employed, academic/self-employed);
health-related behaviour including physical activity
(physical training during summers or winters for at least
one hour a week), excessive/high-risk alcohol consump-
tion (> 30 g alcohol/day for men and > 20 g alcohol/day
for women [27]), smoking habits (current, former, or
never-smoker), and diet (gender-specific tertiles from a
validated food-frequency questionnaire reflecting food
quality [28]); as well as subject’s self-reported medical
history including hypertension, myocardial infarction,
stroke, and diabetes mellitus. Because income is a
household-level variable, “equalized” household income
(in Euros) was calculated using the commonly adopted
procedure of the Luxembourg Income Study to divide
the household income by the square root of the number
of household members [29]. Somatometric measures
included waist circumference (WC), measured to the
nearest 0.1 cm using an inelastic tape midway between
the lower rib margin and the iliac crest in the horizontal
plane with the subject standing comfortably with weight
distributed evenly on both feet. We measured HRQoL
using the two SF-12 components PCS-12 and MCS-12.
To assess SRH, we used the single-item question: “Over
the last 12 months would you say your health has been
very good, good, fair, poor, or very poor?”
Laboratory assessment of the multi-biomarker panel
included measurement of 10 biomarkers from distinct
biological pathways associated with increased morbidity
and mortality including inflammation [high sensitive C-
reactive protein (hs-CRP)], hemostasis (fibrinogen),
metabolic disturbances [glycated hemoglobin (HbA1c),
total cholesterol, and triglycerides], liver disease [gamma
glutamyltransferase (GGT)], kidney disease [urine albu-
min and glomerular filtration rate (GFR)], thyroid status
[thyrotropin (TSH)], and hypothalamic-pituitary-adrenal
axis activity [insulin-like growth factor-I (IGF-I)]. Bio-
markers were measured as follows: hs-CRP determined
immunologically on a Behring Nephelometer II with
commercially available reagents from Dade Behring
(Dade Behring, Eschborn, Germany); plasma fibrinogen
assayed according to Clauss using an Electra 1600 analy-
zer (Instrumentation Laboratory, Barcelona, Spain);
HbA1c determined by high-performance liquid chroma-
tography (Bio-Rad Diamat, Munich, Germany); total
cholesterol measured photometrically (Hitachi 704,
Roche, Mannheim, Germany); triglyceride determined
enzymatically using reagents from Roche Diagnostics
(Hitachi 717, Roche Diagnostics, Mannheim, Germany);
urine albumin determined on a Behring Nephelometer
(Siemens BN albumin; Siemens Healthcare, Marburg,
Germany); GGT measured photometrically (Hitachi 717;
Roche Diagnostics, Mannheim, Germany); creatinine
determined with the Jaffé method (Hitachi 717, Roche
Diagnostics, Germany) and the GFR estimated according
to the modified MDRD formula [30]; TSH measured by
immunochemiluminescent procedures (Byk Sangtec
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by automated two-site chemiluminescence immunoas-
says (Nichols Advantage; Nichols Institute Diagnostica
GmbH, Bad Vilbel, Germany) [26].
Information on vital status were acquired at regular
intervals from time of enrollment into the study through
December 15, 2009. Individuals were censored at either
death or loss to follow-up. The number of months
between baseline examination and censoring was used
as follow-up length.
Statistical analysis
Data on quantitative and qualitative characteristics are
expressed as median (inter-quartile range), or percent,
respectively. Intergroup comparisons with regard to vital
status were performed using c
2 test (qualitative data) or
a Mann-Whitney-U test (quantitative data). PCS-12 and
MCS-12 were divided into quartiles to calculate crude
incidence rates (per 1000 person-years) and to perform
multivariable Cox proportional-hazards regression mod-
els associating PCS-12, MCS-12, and SRH with all-cause
mortality. Kaplan-Meier survival curves were graphed
for SRH and compared using the log-rank test. First, we
prespecified gender- and age-adjusted Cox models and
included alternately socio-demographic factors (civil sta-
tus, educational level, occupational status, and equalized
income), behavioral factors (smoking status, alcohol
consumption, physical activity, food consumption, and
WC), comorbidities (hypertension, myocardial infarc-
tion, stroke, and diabetes mellitus), and the multi-bio-
marker panel (hs-CPR, fibrinogen, HbA1c, total
c h o l e s t e r o l ,t r i g l y c e r i d e ,G F R ,a l b u m i n ,G G T ,T S H ,a n d
IGF-I). In secondary analyses, we used backward (p ≥
0.20 for removal) and forward elimination (p < 0.05 for
inclusion) procedures to identify a parsimonious adjust-
ment set among all of the applied standard covariates
and the multi-biomarker panel.
To compare the predictive performance of the imple-
mented models, we measured the area under the recei-
ver operating characteristic (ROC) curve, or C-statistic,
and tested their differences using STATA’s “roccomp”
command. The C-statistic ranges from 0.5 (no discrimi-
nation) to a theoretical maximum of 1 (perfect discrimi-
nation) and is equivalent to the probability that the
predicted risk is higher for a case (decedent) than for a
non-case (survivor) [31]. Furthermore, we estimated the
integrated discrimination improvement (IDI) to examine
whether the prediction on the basis of a model without
the biomarker panel was significantly improved after
inclusion of the biomarker panel [32]. In contrast to the
net reclassification improvement which needs a priori
meaningful predicted risk categories, the integrated dis-
crimination improvement is based on continuous differ-
ences in the predicted risk from new and old models.
IDI were obtained with logistic regression models that
examined deaths through 10-years of follow-up.
We assessed the potential effect modification of the
investigated associations by age and gender through addi-
tional inclusion of multiplicative interaction terms (age
and gender * HRQoL and SRH, respectively) into the
applied multivariable Cox models. To account for the
potential impact of changing risk factor patterns over
time, we entered the applied adjustment sets as time-vary-
ing covariates into the analysis. Further sensitivity analyses
were performed by recalculating the applied models strati-
fied by 20-year age-groups and gender, as well as adjusting
for possible non-response bias by using inverse probability
weights [33]. An elevated level of item nonresponse of >
5% was an issue with regard to the MCS-12 and PCS-12.
Therefore we used multiple imputations by chained equa-
tions (MICE) as an extremely suitable algorithm to obtain
completed versions of incomplete MCS-12 and PCS-12
[34,35]. Item nonresponse from all further variables was
less than 2%. We verified that the assumption of propor-
tionality of hazards was satisfied. Hazard ratios (HR) were
calculated with a 95% confidence interval (95% CI). We
considered two-sided P value less than p < 0.05 to be sta-
tistically significant. This manuscript was written in accor-
dance with the STROBE statement, giving guidelines for
reporting of observational studies [36]. All statistical ana-
lyses were performed using Stata 11.0 (Stata Corporation,
College Station, TX).
Results
Data on subjective health measures, biomarkers, and
covariates are presented in Table 1. During 41,180 per-
son-years (mean, 9.7 years; 25
th,9 . 3 ;7 5
th, 10.7) of fol-
low-up, 456 individuals (10.7%) died, resulting in an
overall death rate of 11.1 deaths per 1000 person-years.
Crude incidence rates of all-cause mortality decreased
across quartiles of PCS-12 but not MCS-12 (Table 2).
In Cox proportional-hazards models adjusted for gen-
der and age, we found a distinct association between
low PCS-12 scores and all-cause mortality, showing that
subjects with PCS-12 scores in the lowest quartile had
an increased mortality risk (HR 1.75; 95% CI 1.31-2.33)
compared to subjects in the highest quartile. The inclu-
sion of potentially confounding socio-demographic fac-
tors (HR, 1.63; 95% CI, 1.22-2.17), behavioral factors
(HR, 1.78; 95% CI, 1.33-2.40), comorbidities (HR, 1.60;
95% CI, 1.19-2.14), as well as the multi-biomarker panel
(HR, 1.64; 95% CI, 1.19-2.27), attenuated the estimates
only slightly (Table 3). P for trend statistics confirmed
that HRs were linearly elevated across PCS-12 quartiles
in all applied models (p < 0.001). Cox proportional-
hazards analyses for low MCS-12 scores did not yield
any associations with all-cause mortality (Table 3). We
further conducted Cox models for the association of
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Characteristics Survivors (N = 3,803) Decedents (N = 456) p *
Gender, female 53.2 32.2 < 0.001
Age, years 47.0 (34.2; 60.4) 70.3 (63.4; 76.2) < 0.001
Physical component scale (PCS-12) 48.1 (44.2; 50.3) 43.9 (39.1; 48.8) < 0.001
Mental component scale (MCS-12) 44.4 (40.7; 47.6) 46.1 (41.6; 50.2) < 0.001
General health, % < 0.001
very good & good 18.7 5.3
fair 64.5 53.7
poor & very poor 16.8 41.0
Civil status (cohabiting), % 76.3 67.4 < 0.001
Educational level, % < 0.001
< 10 y 35.5 75.3
= 10 y 48.3 17.6
> 10 y 16.2 7.1




No paid job 46.0 90.9
Household income, € 949.0 (636.8; 1214.3) 970.5 (703.0; 1175.0) 0.464




Subject’s medical history, %
Hypertension 20.8 46.2 < 0.001
Myocardial infarction 2.6 9.6 < 0.001
Stroke 1.6 8.1 < 0.001
Diabetes mellitus 4.8 20.2 < 0.001
Riskful alcohol consumption, % 14.8 12.2 0.137
Physically active, % 44.1 24.5 < 0.001
Waist circumference, cm 88.1 (78.0; 98.2) 97.2 (89.0; 104.2) < 0.001




High sensitive C-reactive protein, mg/l 1.25 (0.62; 2.90) 2.48 (1.17; 5.59) < 0.001
Fibrinogen, g/l 2.83 (2.50; 3.33) 3.25 (2.76; 3.80) < 0.001
Glycated hemoglobin, % 5.3 (4.9; 5,7) 5.8 (5.3; 6,4) < 0.001
Total cholesterol, mmol/l 5.66 (4.91; 6.47) 5.89 (5.15; 6.55) 0.009
Triglycerides, mmol/l 1.45 (0.99; 2.22) 1.74 (1.24; 2.68) < 0.001
Albumin (urine), mg/l 7.5 (4.2; 15.2) 12.1 (6.1; 33.6) < 0.001
Gamma glutamyltransferase, μmol/L s 0.33 (0.23; 0.55) 0.40 (0.27; 0.76) < 0.001
Glomerular filtration rate, ml/min 75.3 (66.7; 84.1) 66.8 (56.8; 78.4) < 0.001
Thyrotropin, mU/l 0.67 (0.45; 0.98) 0.59 (0.36; 0.91) < 0.001
Insulin-like growth factor-I, ng/ml 136.0 (105.2; 174.4) 107.5 (82.6; 142.2) < 0.001
Data are percentages or median (25
th;7 5
th).
* p-values based on c
2 (qualitative data) or Mann-Whitney-U test (quantitative data).
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reporting “poor” or “very poor” SRH had a twofold
higher mortality risk (HR 2.07; 95% CI 1.34-3.20) com-
pared to subjects reporting “good” or “very good” SRH.
Again, additional adjustment altered the relationship
only slightly (Table 4). The complete regression results
were given as Additional file 1. Kaplan-Meier survival
curves additionally indicated that subjects with “fair”,
“poor”,o r“very poor” SRH had significantly (log-rank
test: p < 0.001) shorter survival times compared to sub-
jects who reported their SRH as “good” or “very good”
(Figure 1).
Initially, we compared the discriminatory power between
the complete self-reported measures panel (incorporating
HRQoL, SRH, socio-demographic, behavioral, and comor-
bidity measures) and the multi-biomarker panel (age, gen-
der, and all 10 biomarkers). The ROC curves depicted in
Figure 2 illustrate the significantly better discriminatory
power of the self-reported measures (C-statistic of 0.883)
compared to the biomarker panel (0.872). To evaluate the
added discriminatory power in multivariable Cox models,
we implemented a Cox model only including age and gen-
der, yielding a significantly lower C-statistic of 0.843 (p <
0.001). In order to define a parsimonious adjustment set
for each panel, the conducted variable selection proce-
dures identified gender, age, occupational status, educa-
tional level, cohabitation, smoking, WC, and history of
stroke and diabetes mellitus as relevant socio-demographic
and behavioral covariates for mortality risk prediction
(model 1); and fibrinogen, HbA1c, albumin, and GGT as
the most informative biomarkers (model 2). The calcu-
lated C-statistics confirmed the better discriminatory
power of model 1 (incorporating only SRH and selected
socio-demographic and behavioral covariates, respectively)
Table 2 Crude incidence rates of all-cause mortality by quartiles of PCS-12 and MCS-12
PCS-12 in quartiles
1. Quartile 2. Quartile 3. Quartile 4. Quartile
N 1,054 1,065 1,021 1,119
Person-years 9,715 10,416 9,945 11,102
Number of Deaths
(crude incidence rate per 1000 person-years)
221 (22.7) 93 (8.9) 81 (8.1) 61 (5.5)
MCS-12 in quartiles
1. Quartile 2. Quartile 3. Quartile 4. Quartile
N 1,070 1,103 1,023 1,063
Person-years 10,458 10,799 9964 9959
Number of Deaths
(crude incidence rate per 1000 person-years)
96 (9.2) 90 (8.3) 97 (9.7) 173 (17.4)
PCS-12, Physical Component Summary; MCS-12, Mental Component Summary.
Table 3 Adjusted hazard ratios (HR, 95% CI) for quartiles of PCS-12 and MCS-12 associated with all-cause mortality
PCS-12 in quartiles
(Ref.: highest quartile) min/43.6 43.6/47.5 47.5/50.1 p for Trend
Model 1: adjusted for age & gender 1.75 (1.31; 2.33) * 1.12 (0.81; 1.55) 1.07 (0.77; 1.49) < 0.001
Model 1 + socio-demographic factors
a 1.63 (1.22; 2.17) * 1.08 (0.78; 1.50) 1.03 (0.74; 1.44) < 0.001
Model 1 + behavioral factors
b 1.78 (1.33; 2.40) * 1.13 (0.81; 1.58) 1.08 (0.77; 1.52) < 0.001
Model 1 + comorbidities
c 1.60 (1.19; 2.14) * 1.08 (0.77; 1.49) 1.03 (0.74; 1.45) < 0.001
Model 1 + biomarker panel
d 1.64 (1.19; 2.27) * 1.08 (0.75; 1.55) 1.08 (0.75; 1.56) < 0.001
MCS-12 in quartiles
min/40.8 40.8/44.4 44.4/48.0 p for Trend
Model 1: adjusted for age & gender 0.97 (0.75; 1.24) 0.91 (0.70; 1.17) 0.84 (0.65; 1.08) 0.759
Model 1 + socio-demographic factors
a 0.98 (0.76; 1.26) 0.98 (0.75; 1.26) 0.87 (0.68; 1.12) 0.944
Model 1 + behavioral factors
b 1.06 (0.82; 1.37) 0.95 (0.73; 1.23) 0.88 (0.68; 1.13) 0.707
Model 1 + comorbidities
c 0.96 (0.74; 1.23) 0.92 (0.71; 1.19) 0.87 (0.68; 1.12) 0.689
Model 1 + biomarker panel
d 0.97 (0.74; 1.28) 0.93 (0.70; 1.23) 0.85 (0.65; 1.12) 0.840
* p < 0.05; HR, hazard ratio; 95% CI, 95% confidence interval; PCS-12, Physical Component Summary; MCS-12, Mental Component Summary.
a, HR adjusted for age, gender, civil status, educational level, occupational status, and equalized income.
b, HR adjusted for age, gender, smoking status, alcohol consumption, physical activity, food consumption, and waist circumference.
c, HR adjusted for age, gender, previous history of hypertension, myocardial infarction, stroke, and diabetes mellitus.
d, HR adjusted for age, gender, high sensitive C-reactive protein, fibrinogen, glycated hemoglobin, total cholesterol, triglycerides, glomerular filtration rate,
albumin, gamma glutamyltransferase, thyrotropin, and insulin-like growth factor-I.
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markers), yielding a significantly higher C-statistic of 0.883
vs. 0.873 (p = 0.010). Finally, we combined both reduced
models (SRH, selected covariates, and selected biomarkers)
and detected the best discriminatory power with a signifi-
cantly higher C-statistic of 0.887 (p < 0.001) compared to
the previously presented separate assessment of model 1
(0.883) or model 2 (0.873). We confirmed this finding
with a highly significant IDI, estimated at 1.5% (p < 0.001).
Sensitivity analyses with the inclusion of multiplicative
interaction terms did not yield any significant effect
modification caused by gender or age (p < 0.05).
Furthermore, we found virtually no differences compar-
ing the risk estimates between Cox models with and
without time-varying covariates. Stratified analyses
revealed that especially middle-aged men (40-59 years)
were responsive to the detected associations of low
PCS-12 (HR, 3.61; 95% CI, 1.43-9.14) and poor SRH
(HR, 4.37; 95% CI, 1.27-15.04) with all-cause mortality.
Finally, the additional inclusion of non-response weights




The present study investigated the associations between
subjective health, multiple biomarkers, and mortality
Table 4 Adjusted hazard ratios (HR, 95% CI) for self-rated health (SRH) associated with all-cause mortality
SRH in categories
(Ref.: subjects rating SRH “very good” or “good”) “fair”“ poor & very poor”
Model 1: adjusted for age & gender 1.23 (0.81; 1.88) 2.07 (1.34; 3.20) *
Model 1 + socio-demographic factors
a 1.17 (0.76; 1.78) 1.88 (1.21; 2.90) *
Model 1 + behavioral factors
b 1.16 (0.75; 1.80) 2.00 (1.28; 3.12) *
Model 1 + comorbidities
c 1.18 (0.77; 1.81) 1.87 (1.20; 2.91) *
Model 1 + biomarker panel
d 1.11 (0.70; 1.75) 1.63 (1.02; 2.62) *
* p < 0.05; HR, hazard ratio; 95% CI, 95% confidence interval.
a, HR adjusted for age, gender, civil status, educational level, occupational status, and equalized income.
b, HR adjusted for age, gender, smoking status, alcohol consumption, physical activity, food consumption, and waist circumference.
c, HR adjusted for age, gender, previous history of hypertension, myocardial infarction, stroke, and diabetes mellitus.
d, HR adjusted for age, gender, high sensitive C-reactive protein, fibrinogen, glycated hemoglobin, total cholesterol, triglycerides, glomerular filtration rate,
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Figure 1 Kaplan-Meier survival curves for self-rated health
associated with 10-year mortality risk. Subjects with “fair”, “poor”,
or “very poor” self-rated health had a significantly shorter survival
compared to subjects with “good” or “very good” self-rated health
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1-Specificity
Subjective health measures & covariates (AUC:0.883)
Multi-biomarker panel & age, gender (AUC:0.872)
Test of the differences in AUC: P=0.009
ROC analysis for mortality risk prediction
Figure 2 Receiver-operating characteristic (ROC) curves for
mortality risk predicted by subjective health measures and
covariates vs. multi-biomarker panel. The Cox model including
subjective health measures and covariates incorporated age, gender,
self-rated health, PCS-12, MCS-12, civil status, educational level,
occupational status, equalized income, smoking status, alcohol
consumption, physical activity, food consumption, waist
circumference, previous history of hypertension, myocardial
infarction, stroke, and diabetes mellitus vs. a multi-biomarker panel
including age, gender, high sensitive C-reactive protein, fibrinogen,
glycated hemoglobin, total cholesterol, triglycerides, glomerular
filtration rate, albumin, gamma glutamyltransferase, thyrotropin, and
insulin-like growth factor-I.
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that poor SRH and low PCS-12 scores were significantly
associated with increased risk of all-cause mortality,
independent of a broad spectrum of standard covariates
and multiple biomarkers. Second, we found that a risk
assessment using subjective health instruments and
standard covariates yielded a better mortality risk pre-
diction compared to that of a multi-biomarker panel.
Finally, we were able to show that the most accurate
mortality risk prediction was obtained from a combined
assessment of subjective health and biomarkers.
HRQoL & mortality
Our presented risk estimates of the association between
low PCS-12 and mortality were similar to those pre-
viously reported among Taiwanese community-dwelling
elderly [12], but much smaller compared to estimates
among American community-dwelling elderly [10]. We
were not able to detect any association of MCS-12 with
all-cause mortality in the present study. This result is in
line with previous studies based on particular disease
groups [17,19,20,37-39] or community cohorts [10-12],
which similarly found PCS-12 but not MCS-12 asso-
ciated with mortality after multivariable adjustment.
Thus, our findings supports the notion that physical
domains of HRQoL measures are be more tightly related
to mortality compared to mental domains [14,40,41]. As
a potential explanation, it is possible that despite the
high concordance between PCS-12/MCS-12 and SF-36
scores [2], particular aspects of mental functioning are
not captured, ultimately leading to absent associations.
However, it has been shown that the mental health sta-
tus contributes to the PCS-12 as opposed to MCS-12,
most likely due to the strong interrelationship between
physical and mental domains of health [42]. Thus, the
strength of relationship between mental HRQoL and
health outcomes may be diluted due to limitations in
the applied MCS-12 metric.
SRH & mortality
Our observed effect sizes between SRH and mortality
reflect fairly well the range found in the literature,
although the confidence intervals are somewhat wider
[7,43]. Our results are in linew i t hp r e v i o u si n v e s t i g a -
tions suggesting SRH not only as an independent pre-
dictor of mortality risk, but also as a stronger predictor
than HRQoL [40,44]. Because we and previous studies
found the relationship between SRH and mortality to be
stronger in men than in women [6,45], and stronger in
younger than older individuals [46], we conducted sensi-
tivity analyses incorporating interaction terms for gender
and age, but without detecting any significant effect
modification.
Biomarker panel
To the best of our knowledge, this is the first popula-
tion-based study to systematically assess the impact of a
comprehensive multi-biomarker panel on the subjective
health-mortality association. Our finding of an associa-
tion between poor SRH and low PCS-12 scores with
increased mortality risk was independent of a broad
spectrum of multiple biomarkers from distinct biological
pathways. This finding is in line with previous results
from a five-year follow-up of 4,065 individuals aged 71
years or older, showing SRH significantly associated
with mortality risk after adjustment for various biomar-
kers including albumin, white blood cell count, hemo-
globin, high-density lipoprotein cholesterol, and
creatinine [47]. It is important to note that this previous
study included biomarkers only for additional adjust-
ment, but not to assess their comparative predictive per-
formance with regard to mortality risk.
When we applied variable selection procedures to
answer the question which of the 10 biomarkers were
most predictive in terms of mortality risk, we identified
fibrinogen, HbA1c, albumin, and GGT as the most pre-
dictive biomarkers. These pathophysiological highly
plausible mortality risk candidate biomarkers reflect dis-
turbances in hemostasis (fibrinogen), metabolism
(HbA1c), kidney disease (albumin), and liver disease
(GGT). Their predictive ability has been shown to be
similar to the full biomarker panel, suggesting improved
risk stratification effectiveness using this parsimonious
set of biomarkers. But even more interestingly, the pre-
dictive performance of these selected four biomarkers
was shown to be nearly as good as a risk assessment
based on subjective health instruments and standard
covariates. While previous studies accumulated evidence
that subjective health is a powerful mortality risk predic-
tor, the present findings add to the existing literature
indicating that this selected biomarker set plus informa-
tion about gender and age do about as well. Finally, we
were able to show that the combined assessment of sub-
jective health and biomarkers significantly improved the
discriminatory ability of the mortality risk prediction
model beyond that of each separate panel. There is only
one previous study among US veterans that investigated
the predictive power of PCS-12 [43]. Compared to our
estimates, they reported a slightly lower C-statistic of
0.73, which could be explained by sampling artifacts as
veterans tend to be older with a higher proportion of
males than in general populations. However, our results
suggest that the physiological effects of subjective health
measures are synergistic with those captured by the bio-
marker panel, whereas a combined assessment was iden-
tified as the most sensitive barometer of physiologic
states associated with increased mortality risk.
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The strengths of our study include a prospective popula-
tion-based sample of adults aged 20-79 years, a com-
pleted 10-year follow-up period utilizing valid and
reliable mortality data based on a national death regis-
ter, comprehensive subjective health and covariable
assessment, as well as a broad multi-biomarker panel.
Nonetheless, the present study has several limitations.
First, non-response bias may potentially exist in this
sample, because non-response is particular relevant for
self-report of mental properties. But when we performed
sensitivity analyses accounting for non-response bias, we
detected only minimal deviations from our main results.
Second, this study sampled a healthy adult population,
with only 11% of participants deceased over the follow-
up period. But although this proportion is lower than in
several previous studies, a comprehensive review of sin-
gle-item measured SRH and mortality concluded that
studies with lower than 10% mortality found similar
effect sizes as studies with higher mortality rates [7].
Even a study with only 5% decedents demonstrated
similar effect sizes for the association between SF-12
d e r i v e dH R Q o La n dm o r t a l i t yr isk [12]. Third, changes
in HRQoL over time have been suggested to be as
important as the actual baseline value in terms of mor-
tality risk prediction. Studies in selected populations
showed that individuals moving from low to high SF-36
scores (improvement) had similar mortality patterns
than those who scored high over time [11,48]. Although
this analytical approach would have been a valuable
extension of the present study based on baseline mea-
surements, it is yet unclear how a change in HRQoL
over time is related to mortality in the general
population.
Conclusions
The present results from a large population-based epide-
miological study demonstrate that the association of
poor SRH and low PCS-12 with mortality is indepen-
dent of a broad spectrum of standard covariates and
multiple biomarkers from distinct biological pathways.
B u tt h ek e yf i n d i n go ft h ep r e s e n ts t u d yi st h a tas m a l l
set of biomarkers conjointly with subjective health
instruments and socio-demographic standard measures
significantly improved the mortality risk prediction
above and beyond a separate assessment.
While the first finding is more confirmative in nature,
the latter holds important implications from epidemiolo-
gical and public health perspectives. Incorporating both
subjective health assessment and a small set of biomar-
kers into routine data collection could be used to moni-
tor population health, especially to identify
subpopulations particularly at risk. Doing so, the
improved identification of high-risk individuals could
increase this efficacy of disease prevention strategies.
However, further research must be conducted to eluci-
date how subjective health and biomarkers are interre-
lated and interdependent. Carrying the present results
forward to cause-specific mortality and morbidity will
lead to a better understanding of these relationships.
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